SEC Form 4 · accession 0001038133-18-000045
HESKA CORP · HSKA
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Jason D Aroesty
Officer — EVP, International Diagnostics
Period of report
Jul 25, 2018
Accepted (ET)
Jul 27, 2018 · 1:44 pm EDT
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001038133
Table I — non-derivative securities
No Table I lines on this filing.
Table II — derivative securities
| Security | Conv. / exercise price | Date | Code | Shares | A/D | Exercisable | Expires | Underlying | Underlying shares | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Incentive Stock Option (right to buy)F1 | $106.67 | Jul 25, 2018 | A | 2,811 | A | — | Jul 24, 2028 | Common Stock | 2,811 | 2,811 | D |
| Non-Qualified Stock Option (right to buy)F1 | $106.67 | Jul 25, 2018 | A | 17,189 | A | — | Jul 24, 2028 | Common Stock | 17,189 | 17,189 | D |
| Performance SharesF2 | — | Jul 25, 2018 | A | 4,688 | A | — | Mar 31, 2025 | Common Stock | 4,688 | 4,688 | D |
Explanation of responses
- F1The aggregate of these two option awards vests in three approximately equal annual installments beginning on July 25, 2019 and ending on July 25, 2021.
- F2The vesting of each of three approximately equal performance share tranches is contingent on the achievement of certain market-vesting thresholds based on the price per share of Heska's common stock average over a 20-day trailing trading period. The first tranche is to vest at the achievement of $133.34 per share and the second anniversary of grant date. The second tranche is to vest at the achievement of $154.67 per share and the third anniversary of grant date. The third tranche is to vest at the achievement of $186.67 per share and the fourth anniversary of grant date. Any performance shares that do not vest by March 31, 2025 are to be forfeited.